Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial.
Bredewold OW, Chan J, Svensson M, Bruchfeld A, de Fijter JW, Furuland H, Grinyo JM, Hartmann A, Holdaas H, Hellberg O, Jardine A, Mjörnstedt L, Skov K, Smerud KT, Soveri I, Sørensen SS, Zonneveld AV, Fellström B. Bredewold OW, et al. Among authors: de fijter jw. Kidney Med. 2022 Nov 18;5(1):100574. doi: 10.1016/j.xkme.2022.100574. eCollection 2023 Jan. Kidney Med. 2022. PMID: 36593877 Free PMC article.
Everolimus and long-term outcomes in renal transplantation.
Campistol JM, de Fijter JW, Nashan B, Holdaas H, Vítko S, Legendre C. Campistol JM, et al. Among authors: de fijter jw. Transplantation. 2011 Aug 15;92(3 Suppl):S3-26. doi: 10.1097/TP.0b013e3182230900. Transplantation. 2011. PMID: 21799392 No abstract available.
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial.
de Fijter JW, Holdaas H, Øyen O, Sanders JS, Sundar S, Bemelman FJ, Sommerer C, Pascual J, Avihingsanon Y, Pongskul C, Oppenheimer F, Toselli L, Russ G, Wang Z, Lopez P, Kochuparampil J, Cruzado JM, van der Giet M; ELEVATE Study Group. de Fijter JW, et al. Am J Transplant. 2017 Jul;17(7):1853-1867. doi: 10.1111/ajt.14186. Epub 2017 Feb 14. Am J Transplant. 2017. PMID: 28027625 Free article. Clinical Trial.
Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy: An Analysis of the Randomized ELEVATE Study.
Holdaas H, de Fijter JW, Cruzado JM, Massari P, Nashan B, Kanellis J, Witzke O, Gutierrez-Dalmau A, Turkmen A, Wang Z, Lopez P, Bernhardt P, Kochuparampil J, van der Giet M, Murbraech K; ELEVATE Study Group. Holdaas H, et al. Among authors: de fijter jw. Transplantation. 2017 Oct;101(10):2612-2620. doi: 10.1097/TP.0000000000001739. Transplantation. 2017. PMID: 28333860 Clinical Trial.
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.
Fellström BC, Barratt J, Cook H, Coppo R, Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli F, Maes BD, Mercer A, Ortiz F, Praga M, Sørensen SS, Tesar V, Del Vecchio L; NEFIGAN Trial Investigators. Fellström BC, et al. Among authors: de fijter jw. Lancet. 2017 May 27;389(10084):2117-2127. doi: 10.1016/S0140-6736(17)30550-0. Epub 2017 Mar 28. Lancet. 2017. PMID: 28363480 Free article. Clinical Trial.
Serum Potassium and Mortality Risk in Hemodialysis Patients: A Cohort Study.
de Rooij ENM, Dekker FW, Le Cessie S, Hoorn EJ, de Fijter JW, Hoogeveen EK; Netherlands Cooperative Study on the Adequacy of Dialysis-2 (NECOSAD) Study Group. de Rooij ENM, et al. Among authors: de fijter jw. Kidney Med. 2021 Oct 22;4(1):100379. doi: 10.1016/j.xkme.2021.08.013. eCollection 2022 Jan. Kidney Med. 2021. PMID: 35072043 Free PMC article.
Conversion from calcineurin inhibitors to belatacept-based immunosuppressive therapy skews terminal proliferation of non-classical monocytes and lowers lymphocyte counts.
Bredewold OW, van Oeveren-Rietdijk AM, Florijn B, Rotmans JI, de Fijter JW, van Kooten C, van Zonneveld AJ, de Boer HC. Bredewold OW, et al. Among authors: de fijter jw. Transpl Immunol. 2024 Feb;82:101976. doi: 10.1016/j.trim.2023.101976. Epub 2024 Jan 8. Transpl Immunol. 2024. PMID: 38199271 Free article. Clinical Trial.
Attenuation of Torque teno viral load over time in kidney transplantation recipients treated with calcineurin inhibitors is mitigated after conversion to belatacept.
Bredewold OW, Moest WT, de Fijter JW, Meijers E, Bruchfeld A, Skov K, Svensson MHS, Chan J, Mjornstedt L, Sorensen SS, Fellstrom B, Feltkamp MCW, van Zonneveld AJ, Rotmans JI. Bredewold OW, et al. Among authors: de fijter jw. J Med Virol. 2024 Sep;96(9):e29905. doi: 10.1002/jmv.29905. J Med Virol. 2024. PMID: 39228322
324 results